Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Tosoh Bioscience announces GPC glossary and column selection mobile app

Tosoh Bioscience LLC has announced the availability of the GPC Glossary and Column Selection Guide app, which offers easy access to 200 Gel Permeation Chromatography (GPC) terms and a GPC column selection wizard for precise directions to the ideal GPC columns for polymer molar mass distribution characterization.

2 May 2013

Viewpoints: Bowles, Simpson renew push for 'grand bargain;' The debate on FDA oversight of pharmacies; Kasich and feds work to find formula for Medicaid expansion

To be sure, some progress has been made the past two years. Policymakers have enacted about $2.7 trillion in deficit reduction, primarily through cuts in discretionary spending and higher taxes on wealthy individuals. Yet what we have achieved so far is insufficient.

30 Apr 2013

RainDance Technologies announces closing of $20M Series E financing round

RainDance Technologies, Inc., the Digital Biology Company, today announced the closing of a $20 million Series E financing round. The company also announced that Myriad Genetics, Inc. has joined as a new strategic equity investor.

29 Apr 2013

Thermo Fisher Scientific brings several innovations in bioprocessing technologies and systems

Thermo Fisher Scientific Inc., the world leader in serving science, today debuted several innovations in bioprocessing technologies and systems that address the evolving requirements of drug discovery and production for global biopharmaceutical and pharmaceutical manufacturers.

From Thermo Fisher Scientific Inc. 26 Apr 2013

Dyax reports Q1 2013 financial results; LFRP portfolio continues to be a growth driver

Dyax Corp. today announced financial results for the first quarter ended March 31, 2013. The Company will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and updates regarding its key value drivers - the KALBITOR® (ecallantide) business, the broader angioedema portfolio and the Licensing and Funded Research Program (LFRP).

26 Apr 2013

Rochester Medical's net sales increase 8% to $16,635,000 in second quarter 2013

Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.

26 Apr 2013

Greatbatch reports 19% increase in adjusted diluted EPS targets for first quarter 2013

Greatbatch, Inc., today announced results for its first quarter ended March 29, 2013 highlighted by a 19% increase in adjusted diluted EPS despite negative 4% constant currency organic revenue growth.

26 Apr 2013

IGI Laboratories net revenues increase 101% to $3.7M in first quarter 2013

IGI Laboratories, Inc., a New Jersey based topical generic drug development and manufacturing company, announced its financial results for the first quarter ended March 31, 2013.

26 Apr 2013

Personalized knee replacement: an interview with Dr Martin, Preferred Orthopedics of the Palm Beaches

Knee replacement surgery has traditionally been performed using off-the-shelf implants because of the limitations of technology. As with most industries, evolution does occur.

25 Apr 2013

Thermo Scientific Scientific launches HyPerforma SUM DS 300 system for multiple uses

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific HyPerforma Single-Use Mixer DS 300 system, an innovative, cost-effective single-use mixer ideal for pilot-scale liquid preparations for vaccine and biologic manufacturing.

From Thermo Fisher Scientific Inc. 24 Apr 2013

BD receives FDA approval for second prefilled injectable drug

BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD, announced today that the U.S. Food and Drug Administration has approved the second drug to be offered in the recently launched BD Simplist line of ready-to-administer prefilled generic injectables.

From BD (Becton, Dickinson and Company) 24 Apr 2013

GeneCapture developing new device with one-hour pathogen testing capabilities

A company hatched as a partnership between The University of Alabama in Huntsville and chemical engineering professor Dr. Krishnan Chittur is in the design phase for a device that can provide physicians one-hour pathogen testing capabilities.

23 Apr 2013

Aeterna enters into agreements to transfer manufacturing license for Cetrotide to Merck KGaA

Aeterna Zentaris Inc. today announced that its German subsidiary has entered into binding agreements with various partners and licensees with respect to the manufacturing rights and obligations for its Cetrotide® product.

22 Apr 2013

Pelchem and Linde team up to advance MEMS systems

Linde Electronics, the global electronics business of The Linde Group, has strengthened its material support for electronics manufacturing by announcing a strategic partnership with Pelchem, the global fluorochemicals specialist, to accelerate the development of Micro-Electro-Mechanical Systems (MEMS).

22 Apr 2013

DecImmune and DSM to develop proprietary antibody therapeutic

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed an agreement with venture capital funded DecImmune Therapeutics of Cambridge, Massachusetts, USA.

22 Apr 2013

New research on metallic implants could improve quality of life

Coronary stents have saved a lot of lives over the years, but there is a growing interest in what happens when a stent stays inside the body for too long.

22 Apr 2013

Highlights: Local Kan. program seeks to prevent readmissions with food deliveries; Conn. officials want stricter limit on insurer markup

A selection of health policy stories from Kansas, Connecticut, Oregon, the District of Columbia, Texas, Florida, Minnesota and California.

20 Apr 2013

Study finds dietary supplements accounted for more than half the Class 1 drugs recalled by FDA

Dietary supplements accounted for more than half the Class 1 drugs recalled by the U.S. Food and Drug Administration from 2004-12, meaning they contained substances that could cause serious health problems or even death, a new study from St. Michael's Hospital has found.

19 Apr 2013

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.

18 Apr 2013

FDA issues Complete Response Letter to Allergan's NDA for LEVADEX

Allergan, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to its New Drug Application for LEVADEX (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults.

17 Apr 2013

Manufacturing News and Research

Further Reading

Tosoh Bioscience announces GPC glossary and column selection mobile app

Viewpoints: Bowles, Simpson renew push for 'grand bargain;' The debate on FDA oversight of pharmacies; Kasich and feds work to find formula for Medicaid expansion

RainDance Technologies announces closing of $20M Series E financing round

Thermo Fisher Scientific brings several innovations in bioprocessing technologies and systems

Dyax reports Q1 2013 financial results; LFRP portfolio continues to be a growth driver

Rochester Medical's net sales increase 8% to $16,635,000 in second quarter 2013

Greatbatch reports 19% increase in adjusted diluted EPS targets for first quarter 2013

IGI Laboratories net revenues increase 101% to $3.7M in first quarter 2013

Personalized knee replacement: an interview with Dr Martin, Preferred Orthopedics of the Palm Beaches

Thermo Scientific Scientific launches HyPerforma SUM DS 300 system for multiple uses

BD receives FDA approval for second prefilled injectable drug

GeneCapture developing new device with one-hour pathogen testing capabilities

Aeterna enters into agreements to transfer manufacturing license for Cetrotide to Merck KGaA

Pelchem and Linde team up to advance MEMS systems

DecImmune and DSM to develop proprietary antibody therapeutic

New research on metallic implants could improve quality of life

Highlights: Local Kan. program seeks to prevent readmissions with food deliveries; Conn. officials want stricter limit on insurer markup

Study finds dietary supplements accounted for more than half the Class 1 drugs recalled by FDA

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

FDA issues Complete Response Letter to Allergan's NDA for LEVADEX

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy